Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proton-coupled amino acid transporter 2 (SLC36A2) is a membrane protein that functions as a pH-dependent proton-coupled symporter, selectively transporting small amino acids such as glycine, alanine, and proline across cellular membranes. It is electrogenic and exhibits high selectivity for amino acids with small side chains, preferring both L- and D-enantiomers. Expression is notable at the apical membrane of the renal proximal tubule and in the plasma membrane of brown/beige adipocytes, where it also acts as an extracellular amino acid sensor to regulate lysosomal acidification. Mutations in SLC36A2 are associated with inherited metabolic disorders such as iminoglycinuria and hyperglycinuria[1][2][5]. No evidence currently supports its direct targeting by approved or investigational drugs, or its established use as a biomarker or major safety concerns in therapeutic contexts.
Proton-coupled amino acid symport, Electrogenic membrane transport, Small amino acid selectivity (glycine, alanine, proline)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proton-coupled amino acid transporter 2 (SLC36A2).